The vanilloid agonist resiniferatoxin for interventional-based pain control
about
Resiniferatoxin: The Evolution of the "Molecular Scalpel" for Chronic Pain ReliefSurvey of 800+ data sets from human tissue and body fluid reveals xenomiRs are likely artifacts.Positive allosteric modulation of TRPV1 as a novel analgesic mechanism.Transient receptor potential (TRP) channels: a clinical perspectiveMolecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis.Subgroup-elimination transcriptomics identifies signaling proteins that define subclasses of TRPV1-positive neurons and a novel paracrine circuit.Intraganglionic signaling as a novel nasal-meningeal pathway for TRPA1-dependent trigeminovascular activation by inhaled environmental irritants.Experimental evidence for alleviating nociceptive hypersensitivity by single application of capsaicin.Constrained TRPV1 agonists synthesized via silver-mediated intramolecular azo-methine ylide cycloaddition of α-iminoamides.Resiniferatoxin for Pain Treatment: An Interventional Approach to Personalized Pain Medicine.Forced swim-induced musculoskeletal hyperalgesia is mediated by CRF2 receptors but not by TRPV1 receptorsTargeting Pain-evoking Transient Receptor Potential Channels for the Treatment of Pain.IB4(+) and TRPV1(+) sensory neurons mediate pain but not proliferation in a mouse model of squamous cell carcinoma.Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.Transient receptor potential ion channels in primary sensory neurons as targets for novel analgesics.Transient receptor potential channels as targets for phytochemicals.Testing Convergent Evolution in Auditory Processing Genes between Echolocating Mammals and the Aye-Aye, a Percussive-Foraging Primate.[TRPV1 in neuropathic pain: from animal models to therapeutical prospects].Altered pharmacology of native rodent spinal cord TRPV1 after phosphorylation.[EXPRESS]Analgesia by Deletion of Spinal Neurokinin 1 Receptor Expressing Neurons Using a Bioengineered Substance P-Pseudomonas Exotoxin Conjugate.Recent advances in select interventional approaches to cancer-related pain.Local Resiniferatoxin Induces Long-Lasting Analgesia in a Rat Model of Full Thickness Thermal Injury.Natural product modulators of human sensations and mood: molecular mechanisms and therapeutic potential.A hot lunch for herbivores: physiological effects of elevated temperatures on mammalian feeding ecology.Targeting nociceptive transient receptor potential channels to treat chronic pain: current state of the field.Pain control through selective chemo-axotomy of centrally projecting TRPV1+ sensory neurons.Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1.
P2860
Q26741184-201C56DF-32CA-4303-834E-9B1A71CA698DQ30840984-3812639E-1369-4C2D-9CDD-A7580E65EA18Q31099124-F7BE131E-2B95-41B9-A83C-055D7449AF87Q33562143-7299E285-3D2C-48FB-B58A-6B8388575253Q33792431-EC8E326E-0D38-474E-A33C-E56FC567B27AQ34796577-4EE9F8C3-E2E1-4D05-815B-68392BC69B77Q35215947-8116E92E-BB0B-4D20-9044-0B5BF3F8F5C8Q35576844-0CD8550E-A724-47E4-A383-27F4D33B3A88Q36057551-21D53405-AF3B-46F9-B4EE-B95133A87DEDQ36458451-BDF10DE9-F688-4E62-B406-6A20A9805309Q36966268-68398E6B-CC2A-4040-A58D-6FFBC2297B4BQ37362053-09C53611-5475-4FF1-A0F3-AD4F96F7825DQ37616567-C3884A06-78A0-422B-9360-0B3541EE42CCQ38082796-538372BB-A80D-4A05-ABE2-0E539BA42785Q38166804-CB26C1B3-D23B-4060-B497-57356DA630CBQ38220010-2AB28860-BDBA-4D44-BDAC-EFD864CD2439Q38368190-E700A779-2322-4915-8EED-FD1471EF8636Q39223754-9D0EF66F-EBBA-4D24-83FD-EF7D2EA0D094Q39970967-C56630E9-6345-4702-9BD5-9676BB61C7E7Q41544495-EE46DE67-693A-4F62-84A2-450186330478Q46889684-15287412-8256-4150-8C0C-81D8F5D4E84FQ47371201-EF286698-FB70-45D6-856A-9FB4A3A513E8Q47652702-65D80D7C-D62D-4FD9-8B9C-91201E336EDDQ48054564-AA155917-678B-4A9C-B85D-EC2CA3D2440BQ48326480-17FE47FA-83A8-46D4-87D1-3285C020A60CQ50163231-3CCFF439-0846-4C97-BEB4-23C0963C862EQ52350733-BAB2B3B3-4A49-418E-BBB6-B69CF24CF369
P2860
The vanilloid agonist resiniferatoxin for interventional-based pain control
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The vanilloid agonist resiniferatoxin for interventional-based pain control
@ast
The vanilloid agonist resiniferatoxin for interventional-based pain control
@en
The vanilloid agonist resiniferatoxin for interventional-based pain control
@nl
type
label
The vanilloid agonist resiniferatoxin for interventional-based pain control
@ast
The vanilloid agonist resiniferatoxin for interventional-based pain control
@en
The vanilloid agonist resiniferatoxin for interventional-based pain control
@nl
prefLabel
The vanilloid agonist resiniferatoxin for interventional-based pain control
@ast
The vanilloid agonist resiniferatoxin for interventional-based pain control
@en
The vanilloid agonist resiniferatoxin for interventional-based pain control
@nl
P2860
P1476
The vanilloid agonist resiniferatoxin for interventional-based pain control
@en
P2093
Andrew J Mannes
Michael J Iadarola
P2860
P304
P356
10.2174/156802611796904942
P577
2011-01-01T00:00:00Z